Everhart Financial Group »

Lyra Therapeutics shares owned by Everhart Financial Group

Quarter-by-quarter ownership of Lyra Therapeutics (LYRA) shares owned by Everhart Financial Group from 13F filings

Historical chart of Everhart Financial Group investment in Lyra Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lyra Therapeutics held by Everhart Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyra Therapeutics by Everhart Financial Group

Quarter filed Position value Share count Share price at filing
2024-09-30 $65k 253k 0.26

More positions owned by Everhart Financial Group

Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Vanguard Index Fds Value Etf (VTV)
Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Vanguard Index Fds Growth Etf (VUG)
Amazon (AMZN)
Meta Platforms Cl A (META)
Procter & Gamble Company (PG)
JPMorgan Chase & Co. (JPM)
Vanguard Index Fds Sm Cp Val Etf (VBR)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Everhart Financial Group

Top funds holding Lyra Therapeutics

Perceptive Advisors
Citadel Advisors
BlackRock
BlackRock
Samsara BioCapital
Vanguard Group
Ikarian Capital
Sei Investments
Morgan Stanley
Geode Capital Management
Two Sigma Advisers
Two Sigma Investments
State Street Corporation
Everhart Financial Group
Northern Trust

View all funds holding Lyra Therapeutics